Home-Based Study Site
Ioannina, Epirus, Greece
NCT Number: NCT07800039
This randomized controlled trial evaluated the effects of an 8-week Clinical Pilates program on balance and physical function in individuals with multiple sclerosis (MS). Participants were randomly allocated to one of three groups: Clinical Pilates, conventional exercise-based physiotherapy, or a control group receiving postural guidance without a structured rehabilitation program. The two intervention groups completed 16 supervised exercise sessions over 8 weeks. Outcomes included static and dynamic balance, functional mobility, lower-limb motor function, fatigue, and exercise-related motivation. Assessments were conducted at baseline, after 4 and 8 weeks, and at a one-month follow-up.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Ioannina, Epirus, Greece
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants received an 8-week Clinical Pilates-based rehabilitation program comprising 16 sessions, delivered twice weekly with a minimum interval of 48 hours between sessions. Each session lasted approximately 60 minutes and included mobility and breathing exercises, strengthening, balance and coordination exercises, trunk control, core activation, body awareness, and stretching. Exercises were performed in standing, sitting, supine, prone, and side-lying positions. Exercise intensity and complexity were progressively adjusted according to individual ability.
Participants received an 8-week conventional exercise-based physiotherapy program comprising 16 sessions, delivered twice weekly with a minimum interval of 48 hours between sessions. Each session lasted approximately 60 minutes and included progressive strengthening, postural control, sensory integration, balance, and functional training. Exercises progressed from stable to more demanding balance and functional activities, with difficulty individually adjusted according to each participant's abilities and performance.
Time frame: Baseline, Week 4, Week 8, and 1-month follow-up
Center of pressure (CoP) sway area was assessed using a Bertec force platform during six standing conditions: feet together with eyes open, feet together with eyes closed, single-leg stance on the right and left leg, and tandem stance with the right and left foot leading. CoP sway area was used as a measure of static postural control, with lower values indicating less postural sway.
Time frame: Baseline, Week 4, Week 8, and 1-month follow-up
Dynamic balance was assessed using the Mini-Balance Evaluation Systems Test (Mini-BESTest), a 14-item clinical measure assessing anticipatory postural adjustments, reactive postural control, sensory orientation, and dynamic gait. The total score ranges from 0 to 28 points, with higher scores indicating better balance performance.
Time frame: Baseline, Week 4, Week 8, and 1-month follow-up
Center of pressure (CoP) displacement in the mediolateral (ML) and anteroposterior (AP) directions was assessed using a Bertec force platform during six standing conditions: feet together with eyes open, feet together with eyes closed, single-leg stance on the right and left leg, and tandem stance with the right and left foot leading. Lower displacement values indicate less postural sway.
Time frame: Baseline, Week 4, Week 8, and 1-month follow-up
Dynamic balance during walking was assessed using the Functional Gait Assessment (FGA). The FGA consists of 10 items assessing the ability to modify gait while performing different walking tasks. Each item is scored from 0 to 3, giving a total score ranging from 0 to 30. Higher scores indicate better functional gait and dynamic balance.
Time frame: Baseline, Week 4, Week 8, and 1-month follow-up
Lower-limb physical performance was assessed using the Short Physical Performance Battery (SPPB), which includes standing balance, usual gait speed, and repeated chair-stand tests. Each component is scored from 0 to 4, giving a total score ranging from 0 to 12. Higher scores indicate better lower-limb physical performance.
Time frame: Baseline, Week 4, Week 8, and 1-month follow-up
Lower-limb sensorimotor function was assessed using the lower-extremity section of the Fugl-Meyer Assessment (FMA-LE). The assessment evaluates lower-limb motor function, sensation, joint range of motion, and joint pain. Higher scores indicate better lower-limb sensorimotor function.
Time frame: Baseline, Week 4, Week 8, and 1-month follow-up
Fatigue was assessed using the Fatigue Severity Scale (FSS), a 9-item questionnaire evaluating the severity and impact of fatigue on daily functioning. Each item is rated from 1 to 7, with higher scores indicating greater fatigue severity.
Time frame: 2nd, 5th and 8th week
Exercise-related motivation was assessed using selected subscales of the Intrinsic Motivation Inventory (IMI), including interest/enjoyment, perceived competence, perceived choice, and pressure/tension. The IMI was administered only to participants in the two intervention groups. Higher scores reflect greater levels of the construct assessed by each subscale.
University of Patras
Other
Effectiveness of a Clinical Pilates Programme on Static and Dynamic Balance in Individuals With Multiple Sclerosis: A Randomized Controlled Trial
Acronym: MS-PILATES
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02511028
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Bethesda, Maryland, United States
View Trial DetailsNCT07380022
Anemia, Autoimmune Diseases
Trikala, Thessaly, Greece
View Trial DetailsNCT02708927
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Bordeaux, France
View Trial DetailsNCT07663266
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Ann Arbor, Michigan, United States
View Trial Details